Major Depressive Disorder With Mixed Features - Extension
NCT01423253
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Lurasidone
Sponsor
Sumitomo Pharma America, Inc.